Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 189
8
Diseases
98
Unique genes
0.119
Avg. similarity score
Centronuclear myopathy
Most-connected disease (4 links)
Disease
Searched: myopathy, centronuclear, 5
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
myopathy, centronuclear, 5
Centronuclear myopathy
Congenital fiber type disproportion myopathy
Congenital myopathy
Neuromuscular disease
Congenital structural myopathy
Bjornstad syndrome
Developmental delay with hypotonia, myopathy, and brain abnormalities
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Centronuclear myopathy | 4 | 4 | 22 |
| Congenital fiber type disproportion myopathy | 3 | 3 | 11 |
| Congenital myopathy | 3 | 3 | 45 |
| Neuromuscular disease | 3 | 3 | 40 |
| Congenital structural myopathy | 2 | 2 | 12 |
| Bjornstad syndrome | 1 | 1 | 1 |
| Developmental delay with hypotonia, myopathy, and brain abnormalities | 1 | 1 | 1 |
| myopathy, centronuclear, 5 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| RYR1 | 5 / 8 | Centronuclear myopathy, Congenital fiber type disproportion myopathy, Congenital myopathy, Congenital structural myopathy and 1 more |
| ACTA1 | 4 / 8 | Centronuclear myopathy, Congenital fiber type disproportion myopathy, Congenital myopathy, Neuromuscular disease |
| TPM3 | 4 / 8 | Centronuclear myopathy, Congenital fiber type disproportion myopathy, Congenital myopathy, Congenital structural myopathy |
| CCDC78 | 3 / 8 | Centronuclear myopathy, Congenital myopathy, Congenital structural myopathy |
| MTM1 | 3 / 8 | Centronuclear myopathy, Congenital fiber type disproportion myopathy, Congenital structural myopathy |
| MYH7 | 3 / 8 | Congenital fiber type disproportion myopathy, Congenital myopathy, Neuromuscular disease |
| TTN | 3 / 8 | Centronuclear myopathy, Congenital myopathy, Neuromuscular disease |
| ACTN2 | 2 / 8 | Congenital myopathy, Neuromuscular disease |
| BCS1L | 2 / 8 | Bjornstad syndrome, Neuromuscular disease |
| BIN1 | 2 / 8 | Centronuclear myopathy, Congenital structural myopathy |
| CACNA1S | 2 / 8 | Centronuclear myopathy, Congenital myopathy |
| CHRNA1 | 2 / 8 | Centronuclear myopathy, Congenital myopathy |
| DNM2 | 2 / 8 | Centronuclear myopathy, Congenital structural myopathy |
| GOLGA2 | 2 / 8 | Developmental delay with hypotonia, myopathy, and brain abnormalities, Neuromuscular disease |
| HACD1 | 2 / 8 | Congenital fiber type disproportion myopathy, Congenital myopathy |
| ITGA7 | 2 / 8 | Congenital fiber type disproportion myopathy, Congenital myopathy |
| LMNA | 2 / 8 | Congenital myopathy, Neuromuscular disease |
| MAP3K20 | 2 / 8 | Centronuclear myopathy, Congenital fiber type disproportion myopathy |
| MTMR14 | 2 / 8 | Centronuclear myopathy, Congenital structural myopathy |
| MYF6 | 2 / 8 | Centronuclear myopathy, Congenital structural myopathy |
| SCN4A | 2 / 8 | Congenital myopathy, Neuromuscular disease |
| SELENON | 2 / 8 | Congenital fiber type disproportion myopathy, Congenital myopathy |
| SPEG | 2 / 8 | Centronuclear myopathy, myopathy, centronuclear, 5 |
| TPM2 | 2 / 8 | Congenital fiber type disproportion myopathy, Congenital myopathy |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Cytoskeleton in muscle cells | KEGG | 25 / 232 | 13.2× | 1.51e-21 | 1.40e-18 ✓ sig. |
| Striated Muscle Contraction | Reactome | 12 / 36 | 40.9× | 4.64e-17 | 2.14e-14 ✓ sig. |
| Motor proteins | KEGG | 14 / 194 | 8.8× | 5.12e-10 | 6.44e-8 ✓ sig. |
| Hypertrophic cardiomyopathy | KEGG | 10 / 99 | 12.4× | 7.02e-9 | 6.75e-7 ✓ sig. |
| Dilated cardiomyopathy | KEGG | 10 / 105 | 11.7× | 1.25e-8 | 1.11e-6 ✓ sig. |
| Arrhythmogenic right ventricular cardiomyopathy | KEGG | 6 / 86 | 8.6× | 7.03e-5 | 1.76e-3 ✓ sig. |
| Cardiac muscle contraction | KEGG | 6 / 87 | 8.5× | 7.50e-5 | 1.85e-3 ✓ sig. |
| ALKBH3 mediated reversal of alkylation damage | Reactome | 2 / 4 | 61.3× | 3.91e-4 | 6.83e-3 ✓ sig. |
| Ion homeostasis | Reactome | 4 / 54 | 9.1× | 9.65e-4 | 1.37e-2 ✓ sig. |
| Adrenergic signaling in cardiomyocytes | KEGG | 6 / 154 | 4.8× | 1.61e-3 | 2.02e-2 ✓ sig. |
| Nuclear Envelope Breakdown | Reactome | 2 / 9 | 27.2× | 2.29e-3 | 2.61e-2 ✓ sig. |
| Fructose and mannose metabolism | KEGG | 3 / 34 | 10.8× | 2.62e-3 | 2.88e-2 ✓ sig. |
| Smooth Muscle Contraction | Reactome | 3 / 34 | 10.8× | 2.62e-3 | 2.88e-2 ✓ sig. |
| Biosynthesis of nucleotide sugars | KEGG | 3 / 37 | 9.9× | 3.35e-3 | 3.41e-2 ✓ sig. |
| Amino sugar and nucleotide sugar metabolism | KEGG | 3 / 38 | 9.7× | 3.61e-3 | 3.61e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| muscle organ development | GO:0007517 | 16 / 114 | 26.8× | 7.75e-19 | 9.93e-16 ✓ sig. |
| muscle contraction | GO:0006936 | 14 / 85 | 31.4× | 1.27e-17 | 1.41e-14 ✓ sig. |
| skeletal muscle contraction | GO:0003009 | 9 / 32 | 53.6× | 5.23e-14 | 3.02e-11 ✓ sig. |
| skeletal muscle fiber development | GO:0048741 | 8 / 31 | 49.2× | 3.05e-12 | 1.28e-9 ✓ sig. |
| striated muscle contraction | GO:0006941 | 7 / 24 | 55.6× | 2.82e-11 | 9.46e-9 ✓ sig. |
| sarcomere organization | GO:0045214 | 8 / 43 | 35.5× | 5.33e-11 | 1.66e-8 ✓ sig. |
| skeletal muscle tissue development | GO:0007519 | 8 / 68 | 22.4× | 2.44e-9 | 4.95e-7 ✓ sig. |
| skeletal muscle tissue regeneration | GO:0043403 | 6 / 26 | 44.0× | 3.77e-9 | 7.23e-7 ✓ sig. |
| muscle filament sliding | GO:0030049 | 5 / 15 | 63.6× | 1.03e-8 | 1.74e-6 ✓ sig. |
| cellular response to caffeine | GO:0071313 | 4 / 11 | 69.3× | 2.28e-7 | 2.50e-5 ✓ sig. |
| muscle structure development | GO:0061061 | 4 / 19 | 40.1× | 2.59e-6 | 1.84e-4 ✓ sig. |
| skeletal muscle tissue growth | GO:0048630 | 3 / 6 | 95.3× | 2.77e-6 | 1.93e-4 ✓ sig. |
| muscle cell development | GO:0055001 | 4 / 23 | 33.2× | 5.83e-6 | 3.51e-4 ✓ sig. |
| cardiac muscle cell development | GO:0055013 | 4 / 25 | 30.5× | 8.27e-6 | 4.67e-4 ✓ sig. |
| muscle cell cellular homeostasis | GO:0046716 | 4 / 26 | 29.3× | 9.73e-6 | 5.28e-4 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Centronuclear myopathy | Congenital structural myopathy | 0.296 | 8 | 2.02e-21 | 4.06e-20 ✓ sig. |
| Congenital fiber type disproportion myopathy | Congenital myopathy | 0.163 | 8 | 4.52e-19 | 8.15e-18 ✓ sig. |
| Centronuclear myopathy | Congenital myopathy | 0.115 | 7 | 1.84e-13 | 2.36e-12 ✓ sig. |
| Centronuclear myopathy | Congenital fiber type disproportion myopathy | 0.172 | 5 | 1.68e-12 | 1.96e-11 ✓ sig. |
| Congenital myopathy | Neuromuscular disease | 0.089 | 7 | 1.94e-11 | 2.07e-10 ✓ sig. |
| Congenital fiber type disproportion myopathy | Congenital structural myopathy | 0.143 | 3 | 5.95e-8 | 4.33e-7 ✓ sig. |
| Centronuclear myopathy | myopathy, centronuclear, 5 | 0.043 | 1 | 1.43e-3 | 2.23e-3 ✓ sig. |
| Bjornstad syndrome | Neuromuscular disease | 0.024 | 1 | 2.60e-3 | 3.51e-3 ✓ sig. |
| Developmental delay with hypotonia, myopathy, and brain abnormalities | Neuromuscular disease | 0.024 | 1 | 2.60e-3 | 3.51e-3 ✓ sig. |